[1] |
龚艳君, 霍勇. 复杂高危冠状动脉疾病的介入治疗[J].中国心血管病研究, 2022, 20(3):193-195.
|
[2] |
Achim A, Marc M, Ruzsa Z. Surgical turned-downed CHIP cases-can PCI save the day?[J]. Front Cardiovasc Med, 2022, 9: 872398.
|
[3] |
Burzotta F, Russo G, Ribichini F, et al. Long-term outcomes of extent of revascularization in complex high risk and indicated patients undergoing Impella-protected percutaneous coronary intervention: report from the Roma-Verona Registry[J]. J Interv Cardiol, 2019, 2019:5243913.
|
[4] |
Chieffo A, Burzotta F, Pappalardo F, et al. Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of Interventional Cardiology Working Group Endorsed by Spanish and Portuguese Interventional Cardiology Societies[J]. Int J Cardiol, 2019, 293:84-90.
|
[5] |
Kubiak GM, Ciarka A, Biniecka M, et al. Right Heart Catheterization-Background, Physiological Basics, and Clinical Implications[J]. J Clin Med, 2019, 8(9):1331.
|
[6] |
Yager N, Konduru S, Torosoff M. Nitrates as a marker of multiple co-morbidities and increased mortality in patients undergoing percutaneous coronary intervention (PCI)[J]. Cureus, 2022, 14(3):e23520.
|
[7] |
Suki SZ, Zuhdi A, AA Y, et al. Intervention and in-hospital pharmacoterapies in octogenarian with acute coronary syndrome: a 10-year retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry[J]. BMC Geriatr, 2022, 22(1):23.
|
[8] |
Li CK, Xu Z, Ho J, et al. Association of NPAC score with survival after acute myocardial infarction[J]. Atherosclerosis, 2020, 301:30-36.
|
[9] |
Yeung C, Baranchuk A, Tse G, et al. The importance of measuring coronary blood flow for clinical decision making[J]. Curr Cardiol Rev, 2019, 15(4):320-321.
|
[10] |
Zuin M, Rigatelli G, Daggubati R. Cardiac intensive care management of high-risk percutaneous coronary intervention using the venoarterial ECMO support[J]. Heart Fail Rev, 2020, 25(5):833-846.
|
[11] |
Brener SJ, Cunn GJ, Desai PH, et al. A novel risk score to predict one-year mortality in patients undergoing complex high-risk indicated percutaneous coronary intervention (CHIP-PCI)[J]. J Invasive Cardiol, 2021, 33(4):E253-E258.
|
[12] |
Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers[J]. J Am Coll Cardiol, 2006, 48(12):2546-2552.
|
[13] |
Roule V, Ailem S, Legallois D, et al. Antecubital vs femoral venous access for right heart catheterization: benefits of a flashback[J]. Can J Cardiol, 2015, 31(12):1497.e1-6.
|
[14] |
Shah S, Boyd G, Pyne CT, et al. Right heart catheterization using antecubital venous access: feasibility, safety and adoption rate in a tertiary center[J]. Catheter Cardiovasc Interv, 2014, 84(1):70-74.
|